2m 2m 2m 2m 2m 2m 2m
- $90.6MMarket Cap
- -73.88%1-Year Change
- Medical DevicesIndustry
OUTSET MEDICAL (OM)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 37
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
U.S. stock futures fell on Tuesday after the Senate passed a resolution to reopen the government. Market attention was focused on several company earnings reports and potential Federal Reserve interest rate cuts.
11/11/2025, 8:32 AM • Benzinga
U.S. stock futures fell on Tuesday after the Senate passed a resolution to reopen the government. Markets are anticipating potential Federal Reserve interest rate cuts and watching key company earnings reports.
11/11/2025, 5:39 AM • Benzinga
Peers
Statistics
MoreInformation as of 06/03/2026
Company Profile
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Key Executives
- Leslie L. Trigg
- John L. Brottem
- Marc Nash
- Renee Gaeta
- Dinamarie Stefani
Current Ownership Distribution
- Institutions699.1M (68.41%)
- Mutual Funds318.7M (31.19%)
- Insiders4.1M (0.40%)
- Other0 (0.00%)